Studium Suecicum demonstravit vaccinationem cum cholera post diagnosim cancri colorectalis reducere periculum cancri colorectalis actis mortis et causa mortalitatis. (Online version of Gastroenterology September 15, 2017).
Hoc primum debet esse studium incolarum nationalis ad explorandum relationem inter vaccinationem cum cholera post diagnosim canceris colorectalis et periculum mortis. Studia priora docuerunt choleram vaccinam multiplices effectus in systemate immuni corporis moderando habere et formationem polypi colonorum in muris exemplaribus reducere posse.
The researchers believe that colorectal cancer is more common in developed countries than in developing countries. Perhaps less exposure to microbes in childhood is also associated with an increased risk of developing colorectal cancer in adulthood.
The researchers used the Swedish National Cancer Registration and Prescription Drug Registration Database to retrospectively analyze the data of 175 patients who received cholera vaccine after diagnosis of colorectal cancer from mid-2005 to 2012. As for the reason why the cholera vaccine is unknown, it may be that patients need to travel to other countries.
Analysis ostendit comparationem cum aegris qui cum cholera non vaccinati sunt (525 aegros), aegros qui choleram vaccinum receperunt post diagnosis cancri colorectalis 47% minus periculum mortis cancri colorectalis et 41% altiore periculo mortis. Haec utilitas superstes existit in patientibus diversis aetatibus, generibus, gradibus cancri colorectalis in diagnosi.
Inquisitores hypothesaverunt quod choleram vaccini munere fungere potest in prohibendo progressui cancri colorectalis excitando cellulas immunes ut CD8 cellulas positivas T, macrophages et NK cellulas, et / vel expressionem genesis ad tumorigenesim pertinentia afficiendo. Investigatores credunt, si eventus harum studiorum verificari potest in aliis studiis incolarum fundatis vel in studiis clinicis incertis, usum cholerae vaccini ad auxilium curationi cancri colorectalis non esse impossibilis.
Investigatores studentes infectiones et tumores microbiales magis magisque argumenta investigationis demonstraverunt quae microbes vel eorum fructus systema immunem corporis incitare possunt et beneficia sanitatis ad tutelam quorundam generum tumorum et morborum immunes relatas docuerunt Sed emendatio sanitatis. condiciones nos minus et minus verisimile obtinet sanum immunem systematis microbiali nuditate. Vaccinum oris tutum, quod munus immune augere potest, ut beneficia sanitatis significantia nobis afferat.
